Artificial Intelligence (AI) in Cardiology Market Size and Forecast, 2026-2033 | AI Imaging and Precision Diagnostics Propel Market to USD 14.83 Billion at 31.17% CAGR
Capitalize on rising CVD demand, expanding insurer coverage and AI-QCT adoption to improve diagnostic precision, streamline care and unlock new revenue streams.
Dublin, Nov. 17, 2026 (GLOBE NEWSWIRE) -- "AI in Cardiology Market Size, Share & Trends Analysis Report by Component, Application, Medical Condition, Region, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.
The global AI in cardiology market was valued at an estimated USD 1.69 billion in 2025 and is projected to reach USD 14.83 billion by 2033. The market is expected to expand at a compound annual growth rate of 31.17% from 2026 to 2033, driven by the growing prevalence of cardiovascular diseases, demand for greater diagnostic precision, and continued advances in cardiac imaging technology.
Artificial intelligence is increasingly being integrated into cardiology workflows to support disease detection, clinical diagnosis, risk prediction, treatment planning, and patient management. Healthcare providers are adopting AI-powered solutions to analyze complex cardiovascular data, accelerate clinical decision-making, and improve the consistency of diagnostic results. These capabilities are expanding the role of AI across hospitals, diagnostic imaging centers, specialty clinics, research institutions, and other healthcare settings.
Recent reimbursement developments are also supporting broader clinical adoption. In January 2026, Cleerly, Inc. announced that Aetna had expanded coverage for its AI-QCT plaque analysis technology. The decision is expected to increase access to AI-enabled coronary imaging and support improved diagnosis and risk assessment for coronary artery disease among insured patients.
Cardiovascular Disease Burden Accelerates Market Growth
The increasing incidence of cardiovascular diseases is a major factor influencing AI in cardiology market growth. According to the World Health Organization, cardiovascular diseases remained the leading cause of death globally, accounting for an estimated 19.8 million deaths in 2022, or approximately 32% of all deaths worldwide. In the U.S., the Centers for Disease Control and Prevention reported 919,032 cardiovascular disease deaths in 2023, representing about one in every three deaths.
The widespread prevalence of hypertension, coronary artery disease, heart failure, and cardiac arrhythmias continues to place significant pressure on healthcare systems. Conventional diagnostic and treatment processes can be time-consuming and resource-intensive, creating demand for technologies that improve operational efficiency and clinical accuracy. AI-based cardiology platforms can assist specialists with image interpretation, disease classification, risk stratification, and the identification of clinically relevant patterns in large datasets.
Report Segmentation and Market Coverage
The report analyzes revenue growth and key AI in cardiology market trends at global, regional, and country levels. It provides segment and sub-segment assessments for the 2021-2033 period, enabling organizations to evaluate emerging opportunities and changing competitive conditions.
Market coverage by component includes:
- Software
- Hardware
- Services
Application analysis covers:
- Diagnosis
- Prediction
- Drug Discovery
- Others
Medical condition analysis includes Cardiac Arrhythmias, Heart Failure, Ischemic Heart Disease /CAD, and other cardiovascular conditions. The regional assessment covers North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Country-level analysis includes the U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE, and Kuwait.
Strategic Value of the Report
The report provides comprehensive market intelligence designed to support investment planning, product development, competitive positioning, and market entry decisions. It examines the presence of key industry participants, analyzes growth drivers and future trends, and identifies potential revenue opportunities across components, applications, medical conditions, and geographic markets.
Organizations can use the findings to assess regional demand, compare segment performance, monitor product innovation, and develop strategies aligned with evolving clinical and commercial requirements. The report also offers market estimates, revenue forecasts, trend analysis, competitive strategy insights, and market share assessments to help healthcare companies, technology providers, investors, and other stakeholders make informed business decisions in the rapidly expanding AI in cardiology market.
Key Attributes:
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value (USD) in 2025 | $1.69 Billion |
| Forecasted Market Value (USD) by 2033 | $14.83 Billion |
| Compound Annual Growth Rate | 31.1% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Component Segment
1.2.2. Application Segment
1.2.3. Medical Condition Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Artificial Intelligence in Cardiology Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Case Study Insights
3.4. Artificial Intelligence in Cardiology Market Analysis Tools
3.4.1. Industry Analysis - Porter's Five Forces Analysis
3.4.2. PESTEL Analysis
Chapter 4. Artificial Intelligence in Cardiology Market: Component Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Artificial Intelligence in Cardiology Market Component Movement Analysis
4.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
4.4. Software
4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Hardware
4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Services
4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Artificial Intelligence in Cardiology Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Artificial Intelligence in Cardiology Market Application Movement Analysis
5.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Diagnosis
5.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Prediction
5.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Drug Discovery
5.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Others
5.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Artificial Intelligence in Cardiology Market: Medical Condition Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Artificial Intelligence in Cardiology Market Medical Condition Movement Analysis
6.3. Global Artificial Intelligence in Cardiology Market Size & Trend Analysis, by Medical Condition, 2021 to 2033 (USD Million)
6.4. Cardiac Arrhythmias
6.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Heart Failure
6.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Ischemic Heart Disease /CAD
6.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Others
6.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Artificial Intelligence in Cardiology Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. U.S.
7.4.2. Canada
7.4.3. Mexico
7.5. Europe
7.5.1. UK
7.5.2. Germany
7.5.3. France
7.5.4. Italy
7.5.5. Spain
7.5.6. Norway
7.5.7. Sweden
7.5.8. Denmark
7.6. Asia-Pacific
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. Australia
7.6.5. South Korea
7.6.6. Thailand
7.7. Latin America
7.7.1. Brazil
7.7.2. Argentina
7.8. MEA
7.8.1. South Africa
7.8.2. Saudi Arabia
7.8.3. UAE
7.8.4. Kuwait
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2025
8.4. Company Profiles/Listing
8.4.1. GE Healthcare
8.4.2. Heartflow, Inc.
8.4.3. IDOVEN
8.4.4. CardiAI
8.4.5. Ultromics Limited
8.4.6. Arterys Inc. (Tempus AI)
8.4.7. Ultrasight
8.4.8. Koninklijke Philips N.V.
8.4.9. Vista AI
8.4.10. Viz.ai, Inc.
8.4.11. RSIP Vision
8.4.12. Cleerly, Inc.
8.4.13. Medical AI Co., Ltd.
8.4.14. Anumana, Inc.
8.4.15. Aidoc
8.4.16. Circle Cardiovascular Imaging Inc.
8.4.17. Eko Health, Inc.
8.4.18. cardiomatics.com
List of Tables [91]
List of Figures [89]
Companies Featured
- GE Healthcare
- Heartflow, Inc.
- IDOVEN
- CardiAI
- Ultromics Limited
- Arterys Inc. (Tempus AI)
- Ultrasight
- Koninklijke Philips N.V.
- Vista AI
- Viz.ai, Inc.
- RSIP Vision
- Cleerly, Inc.
- Medical AI Co., Ltd.
- Anumana, Inc.
- Aidoc
- Circle Cardiovascular Imaging Inc.
- Eko Health, Inc.
- cardiomatics.com
For more information about this report visit https://www.researchandmarkets.com/r/jsgb1z
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

